<resource xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://datacite.org/schema/kernel-4" xsi:schemaLocation="http://datacite.org/schema/kernel-4 http://schema.datacite.org/meta/kernel-4.1/metadata.xsd"><identifier identifierType="DOI">10.7939/DVN/10902</identifier><creators><creator><creatorName nameType="Personal">Huang, Vivian</creatorName><givenName>Vivian</givenName><familyName>Huang</familyName><nameIdentifier nameIdentifierScheme="ORCID">0000-0002-4524-9403</nameIdentifier><affiliation>University of Alberta</affiliation></creator><creator><creatorName nameType="Personal">Elahi, Shokrollah</creatorName><givenName>Shokrollah</givenName><familyName>Elahi</familyName><nameIdentifier nameIdentifierScheme="ORCID">0000-0002-7215-2009</nameIdentifier><affiliation>University of Alberta</affiliation></creator><creator><creatorName nameType="Personal">Madsen, Karen</creatorName><givenName>Karen</givenName><familyName>Madsen</familyName><nameIdentifier nameIdentifierScheme="ORCID">0000-0002-8636-0714</nameIdentifier><affiliation>University of Alberta</affiliation></creator><creator><creatorName nameType="Personal">Fedorak, Richard</creatorName><givenName>Richard</givenName><familyName>Fedorak</familyName><nameIdentifier nameIdentifierScheme="ORCID">0000-0002-7382-0080</nameIdentifier><affiliation>University of Alberta</affiliation></creator><creator><creatorName>Dieleman, Levinus</creatorName><affiliation>University of Alberta</affiliation></creator><creator><creatorName nameType="Personal">Wine, Eytan</creatorName><givenName>Eytan</givenName><familyName>Wine</familyName><nameIdentifier nameIdentifierScheme="ORCID">0000-0002-3458-4142</nameIdentifier><affiliation>University of Alberta</affiliation></creator><creator><creatorName nameType="Personal">Lumb, Rowan</creatorName><givenName>Rowan</givenName><familyName>Lumb</familyName><affiliation>University of Alberta</affiliation></creator></creators><titles><title>Elevated Fecal Calprotectin in the Second or Third Trimester of Pregnancy Predicts Preterm Delivery in Women with IBD</title></titles><publisher>UAL Dataverse</publisher><publicationYear>2016</publicationYear><subjects><subject>Medicine, Health and Life Sciences</subject><subject schemeURI="https://www.nlm.nih.gov/mesh/" subjectScheme="MeSH">Crohn's disease</subject><subject schemeURI="https://www.nlm.nih.gov/mesh/" subjectScheme="MeSH">pregnancy</subject><subject schemeURI="https://www.nlm.nih.gov/mesh/" subjectScheme="MeSH">ulcerative colitis</subject><subject schemeURI="https://www.nlm.nih.gov/mesh/" subjectScheme="MeSH">cohort studies</subject><subject schemeURI="https://www.nlm.nih.gov/mesh/" subjectScheme="MeSH">infant</subject><subject schemeURI="https://www.nlm.nih.gov/mesh/" subjectScheme="MeSH">biomarkers</subject><subject schemeURI="https://www.nlm.nih.gov/mesh/" subjectScheme="MeSH">C-reactive protein</subject><subject schemeURI="https://www.nlm.nih.gov/mesh/" subjectScheme="MeSH">inflammatory bowel diseases</subject><subject>faecal calprotectin</subject></subjects><contributors><contributor contributorType="ContactPerson"><contributorName nameType="Personal">Huang, Vivian</contributorName><givenName>Vivian</givenName><familyName>Huang</familyName><affiliation>University of Alberta</affiliation></contributor><contributor contributorType="Producer"><contributorName nameType="Organizational">Preconception and Pregnancy in Inflammatory Bowel Disease Clinical Research Program</contributorName><affiliation>University of Alberta</affiliation></contributor></contributors><dates><date dateType="Created">2015</date><date dateType="Submitted">2016-09-29</date><date dateType="Updated">2017-05-26</date><date dateType="Collected">2014/2017</date></dates><resourceType resourceTypeGeneral="Dataset">Clinical data; Biosamples</resourceType><sizes><size>354026</size></sizes><formats><format>application/pdf</format></formats><version>2.2</version><rightsList><rights rightsURI="info:eu-repo/semantics/openAccess"/><rights/></rightsList><descriptions><description descriptionType="Abstract">The objective of this study was to evaluate whether a FCP measurement in the 2nd or 3rd trimester of pregnancy in women with IBD can predict preterm delivery.</description><description descriptionType="TechnicalInfo">SPSS, 23</description><description descriptionType="Methods">Clinical disease activity scores (modified Harvey Bradshaw Index (mHBI) for Crohn's disease and partial Mayo (pMayo) for ulcerative colitis) were obtained at each study visit. C-reactive protein and Fecal calprotectin were analysed: patients collected a first morning stool sample, which was analyzed for FCP using the Quantum Blue high range reader. Delivery outcomes (preterm (less than 37 weeks) and full term (37 or more weeks) and delivery method) were also obtained after birth.</description></descriptions><geoLocations><geoLocation><geoLocationPlace>Edmonton, Alberta</geoLocationPlace></geoLocation></geoLocations><fundingReferences><fundingReference><funderName>Alberta Innovates - Health Solutions (AIHS); Centre of Excellence for Gastrointestinal Inflammation and Immunity Research (CEGIIR)</funderName></fundingReference></fundingReferences></resource>